Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last --
Change Today 0.00 / 0.00%
Volume 0.0
4168 On Other Exchanges
4168 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

glyconex inc (4168) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GLYCONEX INC (4168)

Related News

No related news articles were found.

glyconex inc (4168) Related Businessweek News

No Related Businessweek News Found

glyconex inc (4168) Details

GlycoNex Inc. develops cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. The company’s technology platform enables glycosphingolipid antigen production and identification; monoclonal antibody production; cancer drug screening; and stable cell line production for monoclonal antibody; and pharmacology/pharmacokinetics assessment. It also offers antibody drugs and monoclonal/polyclonal antibodies for cancer treatment. GlycoNex Inc. was founded in 2001 and is based in New Taipei, Taiwan.

Founded in 2001

glyconex inc (4168) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

glyconex inc (4168) Key Developments

GlycoNex Inc., Annual General Meeting, Jun 25, 2015

GlycoNex Inc., Annual General Meeting, Jun 25, 2015.

GlycoNex Incorporation, Annual General Meeting, Jun 25, 2014

GlycoNex Incorporation, Annual General Meeting, Jun 25, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4168:TT 47.35 TWD +0.15

4168 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4168.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4168 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 277.0x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 180.2x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GLYCONEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at